Reference is made to IDEX Biometrics ASA's disclosure on 4 December 2025 of a
private placement of 7,333,333 shares at NOK 3.00 per share, split into two
tranches.
The issuance of Tranche 2 shares was approved by the Company's EGM on 20
January 2026.
Tranche 2 of the private placement includes 1,642,363 shares, and Altea AS has
subscribed for 975,695 shares in Tranche 2, and thereby passes the 10%
threshold. After completion of Tranche 2, Altea will hold 7,001,622 shares in
IDEX, which represent 10,77% of the shares and voting rights in IDEX.
Contacts
Anders Storbråten, CEO and CFO, Tel: +47 416 38 582
E-mail: ir@idexbiometrics.com
About Us
IDEX Biometrics ASA (OSE: IDEX) is shaping the future of access and payments.
IDEX Biometrics is advancing the future of access and payments with
identity-first biometrics. With over a decade of proprietary innovation, our
solutions are proven in the field, globally certified, and trusted by leading
financial institutions. We serve enterprises, the public sector, banks, and
issuers directly and through partners, delivering secure, seamless experiences
in digital and physical access and payments.
For more information, visit www.idexbiometrics.com
(http://www.idexbiometrics.com/)
This information is subject to disclosure under the Norwegian Securities
Trading Act, §5-12. The information was submitted for publication, through the
agency of the contact persons set out above, at 2026-01-26 20:00 CET.